FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/03/064935 [Registered on: 28/03/2024] Trial Registered Prospectively
Last Modified On: 21/03/2024
Post Graduate Thesis  No 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Other 
Public Title of Study   Anti epileptic drugs and bone health - a cross sectional study of Indians with epilepsy 
Scientific Title of Study   A Cross-Sectional Observational Study To Evaluate The Effect Of Anti-Epileptic Drugs On Bone Health In Indians 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr AKHILA BHANDARKAR P 
Designation  CONSULTANT ENDOCRINOLOGIST 
Affiliation  Justice K.S Hegde Medical Academy 
Address  Department of Endocrinology and Metabolism, Room number10, Justice K.S Hegde Medical Academy, Deralakatte, Mangalore

Dakshina Kannada
KARNATAKA
575018
India 
Phone  9971508069  
Fax    
Email  drakhila.bhandarkar@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr AKHILA BHANDARKAR P 
Designation  CONSULTANT ENDOCRINOLOGIST 
Affiliation  Justice K.S Hegde Medical Academy 
Address  Department of Endocrinology and Metabolism, Room Number10, Justice K.S Hegde Medical Academy,Deralakatte, Mangalore.

Dakshina Kannada
KARNATAKA
575018
India 
Phone  9971508069  
Fax    
Email  drakhila.bhandarkar@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr AKHILA BHANDARKAR P 
Designation  CONSULTANT ENDOCRINOLOGIST 
Affiliation  Justice K.S Hegde Medical Academy 
Address  Department of Endocrinology and Metabolism, Room Number10, Justice K.S Hegde Medical Academy,Deralakatte, Mangalore.

Dakshina Kannada
KARNATAKA
575018
India 
Phone  9971508069  
Fax    
Email  drakhila.bhandarkar@gmail.com  
 
Source of Monetary or Material Support  
Justice K.S Hegde Medical Academy,Deralakatte, Mangalore, Dakshina Kannada District, Karnataka, India. Pin Code 575018 
 
Primary Sponsor  
Name  Nitte Universisty Grant 
Address  Justice K.S Hegde Medical Academy Deralakatte, Mangalore, Karnataka Pin 575018 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr AKHILA BHANDARKAR P  Justice K.S Hegde Medical Academy  Department of Endocrinology and Metabolism, Room 10, Deralakatte, Mangalore, Pin 575018
Dakshina Kannada
KARNATAKA 
9971508069

drakhila.bhandarkar@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Nitte K.S Hegde Medical Academy Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: G409||Epilepsy, unspecified, (2) ICD-10 Condition: M818||Other osteoporosis without currentpathological fracture,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  NIL  NIL 
Comparator Agent  NIL  NIL 
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  All patients on Antiepileptic drugs for a minimum period of 6months
Females Age more than or equal to 20years and premenopausal
Males Age more than or equal to 20years and
below 65years of age
Patients with comorbidities that may not have a major impact on bone health like Hypothyroidism with euthyroid status Hypertension Dyslipidemia Well controlled Diabetes mellitus
 
 
ExclusionCriteria 
Details  Presence of chronic comorbidities which could affect bone mineral density like Chronic kidney disease Primary hyperparathyroidism Rheumatoid arthritis Uncontrolled Diabetes (HbA1C above 7) Hyperthyroidism
Intake of drugs like steroids, estrogen, recombinant Parathormone Calcitonin Diuretics Anticoagulants
Pregnant women
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To study the alterations in bone mineral density, trabecular bone score and bone turnover markers induced by antiepileptic drugs in Indians  Baseline only, since the study is of cross sectional design 
 
Secondary Outcome  
Outcome  TimePoints 
To study the effect of antiepileptic drugs on 25hydroxy vitamin D levels
To compare TBS FRAX with FRAX tool to predict fracture risk

 
Baseline only, since the study is of cross sectional design 
 
Target Sample Size   Total Sample Size="234"
Sample Size from India="234" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/05/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Open to Recruitment 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Origin of proposal

 

Epilepsy is a common neurological disorder encountered in both the outpatient and inpatient services of our hospital. There is a growing body of literature describing the association of bone and mineral metabolism mostly assessing bone mineral density (BMD) using DXA scan in patients on antiepileptic drug (AED)therapy for greater than 6months, more often the enzyme inducing AEDs. With increasing use of non-enzyme inducing AEDs of-late, literature investigating the effect of this group of AEDs , particularly in in the Indian population is, however, limited.

 

 

Rationale of the study

 

Large trials studying the effect of AEDs on qualitative and quantitative bone health , adjusting for confounding factors are sparse. Currently  national or international guidelines for preventive therapy and treatment of drug induced osteoporosis are not available. This study aims to evaluate the bone health using DXA scan with traditional parameter i.e. BMD assessment along with latest and more precise measures of bone micro-architechture called as Trabecular bone Score (TBS) and also using Bone turn-over markers(BTM)  in persons prescribed  AEDs for more than 6months at our centre. The results of this study are expected to add to existing literature and to assist in goal oriented treatment decisions for this specific population


Research question /hypothesis

 

1.What is the effect of  anti-epileptic drug therapy beyond 6months on bone mineral density, trabecular bone score and bone turnover markers in Indian patients?

2.What is the association between anti-epileptic drugs and vitamin D levels?

3.Which among Trabecular bone score – adjusted FRAX (TBS-FRAX) and FRAX tool predict fracture risk better?

 

AIMS

 

To evaluate the bone health using DXA scan with traditional parameter i.e. BMD assessment along with latest and more precise measures of bone micro-architecture called as Trabecular bone Score (TBS) and also using Bone turn-over markers (BTM) in persons prescribed AEDs for more than 6months at our centre

 

The results of this study are expected to add to existing literature and to assist in goal-oriented treatment decisions for this specific population.

 

 

OBJECTIVES

 

Primary Objective:

To study the alterations in bone mineral density, trabecular bone score and bone turn-over markers induced by anti-epileptic drugs in Indians.

 

Secondary Objective:

 

1.To study the effect of anti-epileptic drugs on 25-hydroxy vitamin D levels

2. To compare TBS-FRAX with FRAX tool to predict fracture risk

 

 

Preliminary work done--nil

 

 

METHODOLOGY (WORK PLAN)

 

STUDY DESIGN

Cross sectional observational Study

 

STUDY SETTING

Department of Neurology and Department of Endocrinology, K. S. Hegde Medical College, Mangalore

 

STUDY DURATION

2years

 

 

SAMPLE SIZE

Based on the mean comparison of BMD in an earlier publication (7) in patients on AEDs and healthy controls, SD of lumbar spine region in cases = 0.215 and SD of lumbar spine region in controls = 0.131, mean difference = 0.08 and the effect size = 0.46. At 5% level of significance and 80% power of test and at 1:2 ratio, required sample size is 156 cases and 78 healthy using nMaster software Version 2.0.

Inclusion and Exclusion Criteria as mentioned before

STUDY TOOLS

Dual energy Xray Absorptiometry (DXA) scan  for Bone mineral density assessment and Trabecular Bone Score assessment

Serum levels of Vitamin D, Parathormone

Bone Turn Over markers – ProCollagen 1 peptide (P1NP) and C Telo peptide (CTX)

FRAX tool (free online application)

 

 

 

 

 

STUDY PROTOCOL

After obtaining consent 156 patients qualifying for the study shall be recruited as cases, while age sex and body mass index matched 78 healthy subjects shall be recruited as controls. Relevant history shall be obtained and anthropometry detailed will be noted. 2ml blood sample will be obtained for assessment of Vitamin D levels, parathormone levels and bone turn over markers. Both cases and controls will then be subjected to Dual energy Xray absorptiometry scan for obtained bone mineral density and Trabecular Bone score.HBlood ests for – Vitamin D, PTH and BTM

DXA scan for BMD and TBS


Methods of Statistical Analysis

Statistical analysis will be done using SPSS v29. To test the statistical significance of mean comparison of BMD and Bone turn over markers between patients and controls, student t-test will be applied.

 

SIGNIFICANCE and key outcome/deliverables

Significance 1: There is little Indian evidence on AEDs and osteoporosis. Our investigation can determine if AED use is linked to osteoporosis, including the effect of duration of AED use on bone health.

Key outcome 1: Early DXA scans can detect fracture risk and inculcate measures for prevention of major osteoporotic fractures.

Significance 2: Data on Newer NEIAEDs and effect on bone density/bone turn-over markers are rare

Key outcome 2: The data on NEIAEDs could prove useful in avoiding the particular drugs in patients with increased fracture risk

Significance 3: Most studies use bone mineral density measurement, which is inaccurate at predicting fracture risk. Our research using TBS to describe bone microarchitecture and BTM to describe bone remodelling will help determine the optimal osteoporosis treatment. It also compares the FRAX with TBS-adjusted FRAX to identify osteoporosis therapeutic candidates.

Key outcome 3: This would better identify candidates for osteoporosis intervention more effectively and aid in practical decision making.

Significance 4: The study could examine Vitamin D deficiency in AED-treated patients and whether it increases the risk of osteoporosis.

Key outcome 4:  Regular vitamin D treatment for patients on AED is practical. This modest procedure may prevent catastrophic fractures.

 
Close